Jordan D. Berlin MD, BS

Jordan Berlin, M.D, is a medical oncologist who specializes in gastrointestinal cancers and investigational drug development (Phase I). In his roles as the Co-Leader of the Gastrointestinal (GI) Cancer Research Program and Director of Phase I Research at the Vanderbilt-Ingram Cancer Center, Dr. Berlin serves to coordinate clinical and translational efforts across the cancer center from the research programs to the phase I program as well as from within the GI program labs to GI program clinical trials. He is responsible for advancing preclinical data and investigational drugs to investigator-initiated trials and clinical evaluation.

Dr. Berlin has extensive experience designing investigator-initiated and cooperative group trials as well as experience advising the pharmaceutical industry on trial design and development. Additionally, he mentors several junior investigators in phase I and GI malignancies.